1. Home
  2. IRTC vs BLCO Comparison

IRTC vs BLCO Comparison

Compare IRTC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$170.23

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.56

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRTC
BLCO
Founded
2006
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.0B
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
IRTC
BLCO
Price
$170.23
$17.56
Analyst Decision
Strong Buy
Hold
Analyst Count
14
14
Target Price
$207.14
$17.31
AVG Volume (30 Days)
409.5K
361.8K
Earning Date
02-19-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$702,573,000.00
$4,976,000,000.00
Revenue This Year
$27.20
$8.06
Revenue Next Year
$16.91
$5.79
P/E Ratio
N/A
N/A
Revenue Growth
25.45
6.23
52 Week Low
$86.99
$10.45
52 Week High
$212.00
$18.14

Technical Indicators

Market Signals
Indicator
IRTC
BLCO
Relative Strength Index (RSI) 41.15 63.30
Support Level $173.46 $16.22
Resistance Level $190.00 $17.55
Average True Range (ATR) 6.18 0.37
MACD 0.03 0.00
Stochastic Oscillator 38.46 91.78

Price Performance

Historical Comparison
IRTC
BLCO

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: